Home › NDC Lookup › RxCUI directory › RxCUI 1791495

20 ML idarubicin hydrochloride 1 MG/ML Injection [Idamycin] — RxCUI 1791495

Name: 20 ML idarubicin hydrochloride 1 MG/ML Injection [Idamycin] (RxCUI 1791495)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 1791495 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1791495

Official name20 ML idarubicin hydrochloride 1 MG/ML Injection [Idamycin]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known as20 ML Idamycin 1 MG/ML Injection; Idamycin 20 MG in 20 ML Injection; Idamycin 20 MG per 20 ML Injection

FDA products mapped3

Package NDCs mapped5

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Idarubicin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Idarubicin is used to treat acute myeloid leukemia — a type of blood and bone marrow cancer that affects adults. It's always given alongside other anti-leukemia chemotherapy drugs,...
What exactly is idarubicin being used to treat?
No pills here — idarubicin is given through an IV by a nurse or doctor in a hospital or clinic setting. The infusion itself takes just 10 to 15 minutes, though you'll typically be...
How will I receive this medication? Will I have to take pills at home?

📖 Read our full Idarubicin guide →

🕸️ Concept Web — How 20 ML idarubicin hydrochloride 1 MG/ML Injection... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 20 ML idarubicin hydrochloride 1 MG/ML Injection [Idamycin] RxCUI 1791495 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Idarubicin 5650 IN
- Idarubicin hydrochloride 82124 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Idamycin 224952 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Idarubicin Injection 1791492 SCDF
- Idarubicin hydrochloride Injection 2647541 SCDFP
- Idarubicin Injectable Product 1156281 SCDG
- Idarubicin hydrochloride Injectable Product 2662759 SCDGP
- Idarubicin Injection [Idamycin] 1791494 SBDF
- Idarubicin hydrochloride Injection [Idamycin] 2656800 SBDFP
- Idamycin Injectable Product 1167125 SBDG
- Injection 1649574 DF
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- 20 ML idarubicin hydrochloride 1 MG/ML Injection 1791493 SCD
- Idarubicin hydrochloride 1 MG/ML 996151 SCDC
- Idarubicin hydrochloride 1 MG/ML [Idamycin] 996153 SBDC

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

20 ML idarubicin hydrochloride 1 MG/ML Injection SCD · 1791493
Idarubicin hydrochloride 1 MG/ML SCDC · 996151
Idarubicin Injection SCDF · 1791492
Idarubicin hydrochloride Injection SCDFP · 2647541
Idarubicin Injectable Product SCDG · 1156281
Idarubicin hydrochloride Injectable Product SCDGP · 2662759

Brand-Name Concepts

Idarubicin hydrochloride 1 MG/ML [Idamycin] SBDC · 996153
Idarubicin Injection [Idamycin] SBDF · 1791494
Idarubicin hydrochloride Injection [Idamycin] SBDFP · 2656800
Idamycin Injectable Product SBDG · 1167125
Idamycin BN · 224952

📦 FDA Products & Package NDCs

3 products · 5 package NDCs

5 package NDCs map to RxCUI 1791495 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00013-2576-05	1 VIAL, SINGLE-DOSE in 1 CARTON (0013-2576-05) / 5 mL in 1...	Idamycin PFS	Pfizer Laboratories Div Pfizer Inc	2024-08-12
00013-2576-91	1 VIAL, SINGLE-DOSE in 1 CARTON (0013-2576-91) / 5 mL in 1...	Idamycin PFS	Pfizer Laboratories Div Pfizer Inc	1997-02-17
00013-2586-10	1 VIAL, SINGLE-DOSE in 1 CARTON (0013-2586-10) / 10 mL in 1...	Idamycin PFS	Pfizer Laboratories Div Pfizer Inc	2024-03-11
00013-2586-91	1 VIAL, SINGLE-DOSE in 1 CARTON (0013-2586-91) / 10 mL in 1...	Idamycin PFS	Pfizer Laboratories Div Pfizer Inc	1997-02-17
00013-2596-20	1 VIAL, SINGLE-DOSE in 1 CARTON (0013-2596-20) / 20 mL in 1...	Idamycin PFS	Pfizer Laboratories Div Pfizer Inc	2024-03-11

Observed labelers: Pfizer Laboratories Div Pfizer Inc (5) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J9211	Idarubicin hcl injection	5	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.